Literature DB >> 7412882

Drugs from marine organisms: the target of the Roche Research Institute of Marine Pharmacology in Australia.

K von Berlepsch.   

Abstract

A modern approach to the search for biologically active substances of potential therapeutic use isolated from marine organisms is illustrated by a presentation of the multidisciplinary project pursued by the Roche Research Institute of Marine Pharmacology near Sydney, Australia. This specialized institute is part of the world-wide research endeavour of our company and has now been in operation for five years. Following a brief outline of the technical functions the main scientific achievements published by the scientists of the institute are reviewed. This institute is, to our knowledge, the only one of its kind in private industry and we have attempted to demonstrate how its activities should be viewed in the overall context of today's drug or product development.

Mesh:

Substances:

Year:  1980        PMID: 7412882     DOI: 10.1007/bf01106587

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


  3 in total

1.  Maculotoxin: a neurotoxin from the venom glands of the octopus Hapalochlaena maculosa identified as tetrodotoxin.

Authors:  D D Sheumack; M E Howden; I Spence; R J Quinn
Journal:  Science       Date:  1978-01-13       Impact factor: 47.728

2.  Characterization of the neurotoxic constituents of Conus geographus (L) venom.

Authors:  I Spence; D Gillessen; R P Gregson; R J Quinn
Journal:  Life Sci       Date:  1977-12-15       Impact factor: 5.037

3.  Purification and characterization of a galactan-reactive agglutinin from the clam Tridacna maxima (Röding) and a study of its combining site.

Authors:  B A Baldo; W H Sawyer; R V Stick; G Uhlenbruck
Journal:  Biochem J       Date:  1978-11-01       Impact factor: 3.857

  3 in total
  1 in total

1.  Statistical research on the bioactivity of new marine natural products discovered during the 28 years from 1985 to 2012.

Authors:  Yiwen Hu; Jiahui Chen; Guping Hu; Jianchen Yu; Xun Zhu; Yongcheng Lin; Shengping Chen; Jie Yuan
Journal:  Mar Drugs       Date:  2015-01-07       Impact factor: 5.118

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.